SIGNAL GENETICS

Signal Genetics, Inc., is a commercial-stage, molecular diagnostics company providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma performed at the University of Arkansas for Medical Sciences (UAMS). More than 30 years of clinical research on nearly 10,000 multiple myeloma patients who received their care at UAMS went into the development of Signal Genetics’ flagship product, MyPRS® (Myeloma Prognostic Risk Signature).

#People #Financial #Website #More

SIGNAL GENETICS

Social Links:

Industry:

Health Care Health Diagnostics Innovation Management

Founded:

2010-01-01

Address:

Carlsbad, California, United States

Country:

United States

Website Url:

http://www.signalgenetics.com

Total Employee:

51+

Status:

Active

Contact:

+1 760-537-4100

Total Funding:

25 M USD

Technology used in webpage:

SPF Apache Mobile Non Scaleable Content PHP Apache 2.4 DigiCert SSL CloudFront AWS Global Accelerator OpenSSL New Relic

Current Employees Featured

richard-a-bender_image

Richard A. Bender
Richard A. Bender Chief Medical Officer @ Signal Genetics
Chief Medical Officer
2015-09-01

Stock Details

Company's stock symbol is NASDAQ:SGNL

Investors List

bsl-capital_image

Official Site Inspections

http://www.signalgenetics.com

Host Informations
Whois Informations

Loading ...